Analysed BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) News Sources
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform
09-06-2026
yahoo.com
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum
14-04-2026
yahoo.com
BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day
31-07-2026
yahoo.com
What is the current price of BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS)?
The current price of BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) is $0.3659.
BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) since the previous trading day is $0.0025.
BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) since the previous trading day is 0.6879%.
What is the most recent average sentiment score for BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS)?
The most recent average sentiment score for BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) is 77 out of 100.
What is the most recent average sentiment for BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS)?
The most recent sentiment for BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS) is .
SEC-8K** Filing Available For BIOMARK DIAGNOSTICS INC (BMKDF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.